A class action lawsuit challenging the Trump administration’s campaign to block gender affirming care coverage under federal agencies’ employer-sponsored health insurance program said the move is “akin to denying continuing insulin treatment for someone with diabetes.”

The White House barred insurers from covering gender-affirming care under federal benefit plans. A nonprofit says it’s akin to denying insulin treatment.

A class action lawsuit challenging the Trump administration’s campaign to block gender affirming care coverage under federal agencies’ employer-sponsored health insurance program…